NCT02347501 Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP) Status COMPLETED Phase PHASE2
NCT02346240 Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) Status COMPLETED Phase PHASE3
NCT02330380 Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation Status COMPLETED Phase N/A
NCT02326298 An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) Status COMPLETED Phase PHASE3
NCT02326272 A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) Status COMPLETED Phase PHASE3
NCT02325219 An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT02322580 An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients Status COMPLETED Phase N/A
NCT02322086 A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Status COMPLETED Phase PHASE2
NCT02313922 Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate Status COMPLETED Phase PHASE4
NCT02303509 Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject Status COMPLETED Phase PHASE1
NCT02295865 A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT02294981 Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis Status TERMINATED Phase NA
NCT02274363 A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis Status COMPLETED Phase N/A
NCT02271971 Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis Status COMPLETED Phase NA
NCT02209753 BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT02207244 A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment Status COMPLETED Phase PHASE3